Study May Procced News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study May Procced. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study May Procced Today - Breaking & Trending Today

Inhibikase Therapeutics Announces FDA Clearance of Investigational New Drug Application for IkT-001Pro for the Treatment of Chronic Myelogenous Leukemia

Published: August 26, 2022

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing protein kinase inhibitor...

Source: prnewswire.com

Related Topics:

United StatesMiltonh WernerAlex LoboInhibikase Therapeutics IncCompany ContactDrug AdministrationPrnewswire Inhibikase Therapeutics IncSternir IncAbelson Tyrosine KinasesInvestigational New DrugChronic Myelogenous LeukemiaStudy May ProccedAbelson Tyrosine KinaseOrphan Drug DesignationChief ExecutiveAbleson TyrosineMultiple System AtrophyPrivate Securities Litigation Reform ActInhibikase Therapeutics